Unique ID issued by UMIN | UMIN000020862 |
---|---|
Receipt number | R000024071 |
Scientific Title | Proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy |
Date of disclosure of the study information | 2016/02/03 |
Last modified on | 2018/02/15 20:27:05 |
Proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy
Proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy
Proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy
Proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy
Japan |
Intrahepatic cholangiocarcinoma
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of proton beam therapy for intrahepatic cholangiocarcinoma unsuitable for surgery or chemotherapy in a multicenter study
Safety,Efficacy
Confirmatory
Pragmatic
Phase II
2-year overall survival rate
1)2-year progression free survival rate
2)2-year local progression free survival rate
3)Adverse effect frequency
4)Radiation induced liver disease
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Proton Beam Therapy
22 times, once a day, 5 times a week, maximam 46 days, 30 cases
20 | years-old | <= |
80 | years-old | > |
Male and Female
1)Pathologically proven cholangiocarcinoma (adeno/adenosquamous carcinoma)
2)Inoperable
3)Nonresponsive to chemotherapy
4)Tumor diameter less than 12cm
5)Inclusive in the irradiation field
6)Child-pugh class A/B
7)PS 0-2
8)Both inpatients and outpatients
9)Laboratory data within 14 days before registration as follows:
-White blood cells>=2,000/mm3
- Platelet >=5*104/mm3
-Hemoglobine>=8,0 g/dL
-Total bilirubin<2,0 mg/dL
-Serum Albumin>3,5 g/dL
-Serum creatinine<=1,5 mg/dL
-Prothrombin time(%)>70%
10)Blood transfusion not received within 14 days before registration
11)Age>=20, <80
12)Informed consent obtained
1)Postoperative recurrence
2)Presence of lymph nodes metastases
3)Presence of distant metastases
4)Presence of active double cancers
5)Infection required systematic therapy
6)Body temperature more than 38 degree Celsius at screening
7)Pregnacy,demand of pregnant,28 days within childbirth and lactating
8)Psychosis or complicated mental symptom which causes difficult to entry
9)Steroid or other immunosuppressive drugs usage
10)Uncontrolled diabetes
11)Uncontrolled hypertension
12)Unstable angina within 3 weeks of myocardial infarction within 6 months
13)Presence of interstitial pneumonitis, pulmonary fibrosis, or severe emphysema which is diagnosed by chest CT
14)Esophageal varix (hemorrhagic,history of hemorrhage, more than F2,RC2)
15)Inappropriate decision by a principal investigator
16)Entry to other clinical research
30
1st name | |
Middle name | |
Last name | Hideyuki Sakurai |
University of Tsukuba Hospital
Department of Radiation Oncology
2-1-1, Amakubo, Tsukuba, Ibarali, 305-8576
029-853-7100
hsakurai@pmrc.tsukuba.ac.jp
1st name | |
Middle name | |
Last name | Toshiyuki Okumura |
University of Tsukuba Hospital
Department of Radiation Oncology
2-1-1, Amakubo, Tsukuba, Ibarali, 305-8576
029-853-7100
okumura@pmrc.tsukuba.ac.jp
Department of Radiation Oncology, University of Tsukuba Hospital
Japn Agency for Medical research and Development
Other
NO
2016 | Year | 02 | Month | 03 | Day |
Unpublished
Preinitiation
2016 | Year | 02 | Month | 01 | Day |
2016 | Year | 04 | Month | 01 | Day |
2016 | Year | 02 | Month | 03 | Day |
2018 | Year | 02 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024071